Skip to content

SCHEDULE 13G/AAccepted Jul 28, 5:21 PM ET

Verve Therapeutics, Inc. SCHEDULE 13G/A

GV 2017, L.P.

sec.gov(opens the filing on sec.gov)

Accepted (ET)

5:21 PM

Jul 28, 2025

Filed

Jul 28, 2025

Documents

1

Size

27.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.